Current treatment methods for children and adults with FXS focus on alleviating the symptoms of FXS, such as ADHD and decreased social function, vs. treating the root cause (i.e., loss of FMRP and how the brain is affected). The gene discussed is FMR1; the disease is attention deficit-hyperactivity disorder.